THE COMPANY
Yapan Bio is a Contract Development and Manufacturing Organization (CDMO) serving the needs of the biotechnology industry, globally.
Yapan Bio provides robust process development, appropriate scale-up and compliant GMP manufacturing of Vaccines and Biologics/Bio-therapeutics for human clinical studies across the world.
Yapan Bio has established state-of-the-art Process Development and GMP facilities for vaccines and biologics, including higher Bio-Safety levels (up to BSL-2+).
The team at Yapan includes professional with proven track record and execution skills at top companies in the Industry.
Yapan Bio is located at Genome Valley (Hyderabad, India): A major hub for the Biotechnology and Biopharmaceutical industry.
Piramal Pharma owns 33.33% of Yapan Bio.
VISION
MISSION
To be the preferred collaborative partner to the global biotechnology and biopharma companies for successful development of Vaccines and Biologics/Bio-therapeutics through world-class Research and Development combined with efficient and compliant manufacturing services.
To provide customized high-quality integrated services to our partners. We strive for total customer satisfaction and leadership in CDMO services globally, through excellence in process and manufacturing technologies, based on world-class Research and Development.
QUALITY POLICY
FOCUS AREA
FOUNDERS
Yapan Bio was founded by two industry veterans, Atin Tomar and Nirav Desai, with a proven leadership track record in both technical and leadership roles in the biotechnology industry, globally. They bring >45 years of combined experience in the biotechnology industry including, highly specialized expertise and experience in development, manufacturing and commercialization of novel recombinant vaccines and biologics/bio-therapeutics.
BOARD OF DIRECTORS
AWARDS & RECOGNITIONS
We provide services to develop and manufacture high-quality Vaccines and Biologics/Bio-therapeutic, to support global biotechnology and biopharma companies, meeting customer satisfaction in compliance with Quality, Regulatory and GMP expectations.
Yapan Bio’s focus and expertise is in the development and manufacturing of next generation and highly complex molecules/products (recombinant vaccines, viral and non-viral vector-based products, Gene Therapy, monoclonal antibodies etc.). Yapan Bio has up to biosafety level - two Plus (BSL-2+) facilities, which allows Yapan to work with in highly differentiated areas like Vaccines and Gene Therapy.
Vaccines
-
Recombinant Vaccines (Virus Like Particles, Nano-Particles, Protein antigens etc.)
-
Viral Vector Based Vaccines
-
RNA/DNA Vaccines
Biologics/Bio-therapeutics
-
Gene Therapy
-
Oncolytic Viruses
-
Vectors (Viral & Non-viral), etc.
-
-
Monoclonal Antibodies
-
Therapeutic proteins and other complex biologics